-       Report 
- May 2025
-  240 Pages 
- Global 
   From       €4292EUR$4,799USD£3,776GBP 
            -       Report 
- October 2025
-  188 Pages 
- Global 
   From       €3171EUR$3,545USD£2,789GBP 
      €3523EUR$3,939USD£3,099GBP 
          -       Report 
- October 2025
-  264 Pages 
- Global 
   From       €5233EUR$5,850USD£4,603GBP 
          -       Report 
- September 2025
-  250 Pages 
- Global 
   From       €4016EUR$4,490USD£3,533GBP 
            -       Report 
- October 2025
-  197 Pages 
- Global 
   From       €3171EUR$3,545USD£2,789GBP 
      €3523EUR$3,939USD£3,099GBP 
           -       Report 
- June 2025
-  400 Pages 
- Global 
   From       €4427EUR$4,949USD£3,894GBP 
          -       Report 
- March 2024
-  110 Pages 
- Global 
   From       €5322EUR$5,950USD£4,681GBP 
            -       Report 
- September 2022
-  30 Pages 
- Global 
   From       €1968EUR$2,200USD£1,731GBP 
      €2460EUR$2,750USD£2,164GBP 
          -       Report 
- May 2024
-  200 Pages 
- Global 
   From       €3712EUR$4,150USD£3,265GBP 
          -       Report 
- April 2023
-  220 Pages 
- Global 
   From       €3220EUR$3,600USD£2,832GBP 
          -       Report 
- October 2023
-  140 Pages 
- Global 
   From       €3980EUR$4,450USD£3,501GBP 
          -       Report 
- June 2024
-  140 Pages 
- Asia Pacific 
   From       €3461EUR$3,869USD£3,044GBP 
          -       Report 
- June 2024
-  140 Pages 
- Latin America 
   From       €3461EUR$3,869USD£3,044GBP 
          -       Report 
- June 2024
-  140 Pages 
- Europe 
   From       €3461EUR$3,869USD£3,044GBP 
          -       Report 
- February 2024
-  245 Pages 
- Global 
        €4468EUR$4,995USD£3,930GBP 
            -       Report 
- September 2022
-  342 Pages 
- Global 
   From       €6798EUR$7,600USD£5,980GBP 
      €8497EUR$9,500USD£7,475GBP 
          -       Report 
- November 2024
-  89 Pages 
- Global 
   From       €3500EUR$4,192USD£3,186GBP 
          -       Report 
- February 2024
-  87 Pages 
- Global 
   From       €3500EUR$4,192USD£3,186GBP 
          -       Report 
- October 2025
-  50 Pages 
- Global 
   From       €2370EUR$2,650USD£2,085GBP 
          -       Report 
- October 2025
-  50 Pages 
- Global 
   From       €2370EUR$2,650USD£2,085GBP 
       
      The Phentermine market is a subset of the Anti-Obesity Drugs market, which is composed of pharmaceuticals used to treat obesity. Phentermine is a sympathomimetic amine, which is an appetite suppressant that works by stimulating the hypothalamus gland and affecting certain neurotransmitters to decrease appetite. It is typically prescribed for short-term use, as it can be habit-forming and has potential for abuse. Common side effects include dry mouth, insomnia, and increased heart rate.
The    Anti-Obesity Drugs market is composed of a variety of products, including Phentermine, Orlistat, Lorcaserin, and Bupropion. These products are used to treat obesity, either alone or in combination with lifestyle changes such as diet and exercise.
Some companies in the Phentermine market include KVK Tech, Inc., Actavis, Inc., Teva Pharmaceuticals, and Mylan Pharmaceuticals. Show Less   Read more